Smartphone Mechanocardiography used for post-ablation home monitoring to detect atrial fibrillation recurrence: Usability, adherence and re-ablation

Clicks: 7
ID: 337829
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #78 of 80 articles by views in European Heart Journal - Digital Health

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract Aims Recurrence of atrial fibrillation (AF) following catheter ablation is common but may be underdetected using conventional intermittent monitoring. Smartphone-based Mechanocardiography (MCG) enables low-burden rhythm assessment; however, evidence regarding its real-world applicability in the post-ablation setting remains limited. We aimed to evaluate the feasibility, usability, and clinical relevance of MCG-based home monitoring after AF ablation, and to explore its association with re-ablation. Methods and results In this prospective single-center study, 640 consecutive patients with paroxysmal and persistent AF undergoing AF ablation were offered home monitoring using the CardioSignal® smartphone application. Among these, 521 (81%) were active users during the first month, and 354 (68%) remained active at 6 months. 8,240 recordings were performed in the first month, declining to 2,869 at 6 months. AF recurrence was detected in 40% of active users during the first 3 months and in 30% during months 4-6, with clear early clustering. Usability was high: 95% of survey respondents (n=338) reported the app was easy to use, and 91% perceived monitoring as valuable. In a predefined Danish subcohort (n=164), Kaplan-Meier survival analysis demonstrated early AF recurrence detected by MCG was strongly associated with re-ablation within 12 months (log-rank p< 0,0002), occurring in 27.6% of patients with early AF recurrence vs. 4.5% without. Conclusion Smartphone-based MCG is a feasible, well-accepted method for patient-initiated, low-burden event monitoring. Early AF recurrence detected by MCG is common and associated with re-ablation, supporting its role in early risk stratification and post-procedural management.
Reference Key
openalex_W7224168189 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal European Heart Journal - Digital Health
Year 2026
DOI
10.1093/ehjdh/ztag173
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.